BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16014318)

  • 1. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Control Release; 2005 Oct; 107(2):215-28. PubMed ID: 16014318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Drug Target; 2006 Nov; 14(9):632-45. PubMed ID: 17090399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
    Venkateswarlu V; Manjunath K
    J Control Release; 2004 Mar; 95(3):627-38. PubMed ID: 15023472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of nitrendipine solid lipid nanoparticles.
    Manjunath K; Venkateswarlu V; Hussain A
    Pharmazie; 2011 Mar; 66(3):178-86. PubMed ID: 21553647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
    Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
    Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
    Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
    Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
    Tian J; Pang X; Yu K; Liu L; Zhou J
    Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles.
    Hu L; Jia H; Luo Z; Liu C; Xing Q
    Pharmazie; 2010 Feb; 65(2):110-3. PubMed ID: 20225654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
    Varshosaz J; Minayian M; Moazen E
    J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced brain targeting efficacy of Olanzapine through solid lipid nanoparticles.
    Natarajan J; Baskaran M; Humtsoe LC; Vadivelan R; Justin A
    Artif Cells Nanomed Biotechnol; 2017 Mar; 45(2):364-371. PubMed ID: 27002542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
    Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
    Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
    He J; Hou SX; Feng JF; Cai BQ
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1651-3. PubMed ID: 16400939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside.
    Zhang X; Lü S; Han J; Sun S; Wang L; Li Y
    Pharmazie; 2011 Jun; 66(6):404-7. PubMed ID: 21699077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
    Kumar VV; Chandrasekar D; Ramakrishna S; Kishan V; Rao YM; Diwan PV
    Int J Pharm; 2007 Apr; 335(1-2):167-175. PubMed ID: 17161566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of In Vivo Efficacy and Oral Bioavailability of Aripiprazole with Solid Lipid Nanoparticles.
    Silki ; Sinha VR
    AAPS PharmSciTech; 2018 Apr; 19(3):1264-1273. PubMed ID: 29313261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration.
    Li R; Eun JS; Lee MK
    Arch Pharm Res; 2011 Feb; 34(2):331-7. PubMed ID: 21380818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
    Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
    Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang Z; Lv H; Zhou J
    Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.